: Patient demographics and response rates to therapies like Estetrol (E4) or GPER-targeted treatments.
Draft Outline: "Advancements in Multiple Myeloma and Immunoglobulin Profiling (2023)" MM.IG.(2023).zip
: Data on light chain proteoforms produced by myeloma cells. : Patient demographics and response rates to therapies
Likely Research Context: Multiple Myeloma and Immunoglobulins MM.IG.(2023).zip
: The need for better diagnostic precision through molecular and phenotypic virulence tracking. 2. Materials and Methods
: Multiple Myeloma (MM) as a B-cell malignancy characterized by the secretion of monoclonal immunoglobulins (IG) or light chains.